EU Probes China’s Medical Device Market Access
The European Commission has initiated an investigation into China's public procurement practices for medical devices, increasing [...]
ImmunityBio’s Combination Therapy Approved for Bladder Cancer
The U.S. Food and Drug Administration (FDA) has recently approved ImmunityBio's combination therapy for vaccine-resistant bladder [...]
Expansion and Enhancement of Telehealth and Teletherapy Services Post-Pandemic
The pandemic significantly highlighted the benefits of telehealth, making remote medical consultations a preferred choice for [...]
HEOR & Market Access Global Salary Survey (2024)
Unlock the Latest Insights in HEOR & Market Access with the 2024 Global Salary Survey Are [...]
FDA Delays Approval of Eli Lilly’s Alzheimer’s Drug Donanemab, Citing Safety and Efficacy Concerns
Eli Lilly's Alzheimer's drug donanemab faces delays in FDA approval due to concerns over safety and [...]
Beyond Accelerated Approvals: External Control Arms
Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring products to market in a shorter time and for lower costs.
3rd Real World Evidence and Market Access
RWE serves as a multifaceted tool, enhancing safety and efficacy data, demonstrating a product’s value and cost-effectiveness to payers, and [...]
Can We Trust the Data? The Case for Validation
Real world research has produced recent newsworthy findings on topics as diverse as COVID, mental health, cancer, and dementia. [...]
Sanofi CEO Paul Hudson Outlines Bold M&A and R&D Strategy for a Transformative Year Ahead
At the JP Morgan Healthcare Conference, Sanofi CEO Paul Hudson outlined the company's forward-looking strategy, emphasizing [...]
Metagenomi Announces IPO Amid Biotech Sector’s Cooling Investor Interest
Metagenomi, a preclinical gene editing biotech, announced its initial public offering (IPO) plans, aiming to list [...]
FDA Approves Groundbreaking CRISPR Gene-Editing Medicine for Sickle Cell Disease
The FDA has approved the world's first CRISPR gene-editing medicine, Casgevy, for sickle cell disease, marking [...]
Global Angiography Catheter Market: Surge in Demand Driven by Minimally Invasive Procedures and Cardiovascular Disease Prevalence
The global angiography catheter market, valued at $1.57 billion in 2024, is expected to grow at [...]
Samsung Bioepis Set to Launch Stelara Biosimilar in 2025 Amid Challenges for Medicare Price Negotiation Exemption
Samsung Bioepis recently finalized an agreement allowing its Stelara biosimilar, SB17, to launch in February 2025. [...]
Pharmaceutical Industry Faces Major Transition as Traditional Commercial Model is Disrupted
The traditional commercial model in pharmaceuticals has been disrupted due to shifts in the healthcare market, [...]
NIH’s New Director Monica Bertagnolli Concerned about Obesity; Emphasizes the Importance of Clinical Trials and Role of Insurers in Healthcare Research
Newly appointed NIH director Monica Bertagnolli expressed her concern about obesity and highlighted the importance of [...]
Real-World Data Empowers Pharma Advertising: An Interview with PurpleLab CEO Mark Brosso
In a conversation with Mark Brosso, the CEO of PurpleLab, it was uncovered that the pharmaceutical [...]
U.S. Men’s Life Expectancy Gap Widens to Largest Since 1996 Amid Public Health Crises and Covid-19 Impact
The life expectancy of men in the U.S. is about six years shorter than women, according [...]
Changes in Health Insurance Cost Estimation Could Boost US Inflation Measures
Starting with the October consumer price index, the Bureau of Labor Statistics (BLS) is changing how [...]
Novo Nordisk Invests $6 Billion in API Production Expansion to Meet High Demand
Novo Nordisk is investing over $6 billion to expand Denmark's active pharmaceutical ingredients (API) production capacity. [...]
Eli Lilly to Release Weight Loss Drug Zepbound at a Discount, Poised for Fierce Competition with Novo Nordisk’s Wegovy
Eli Lilly's weight loss drug Zepbound is set to compete with Novo Nordisk's Wegovy. Zepbound, approved [...]
Eli Lilly’s Tirzepatide Receives FDA Approval for Obesity Treatment Under Brand Zepbound
Eli Lilly’s drug tirzepatide, branded as Mounjaro for type 2 diabetes, has gained FDA approval to [...]
Biogen Q3 Financials: Stable Revenues, Regulatory Success with Leqembi and Zurzuvae Amid Earnings Dip
Biogen has updated its financial outlook, indicating mixed results in its recent quarterly report. The company [...]
Long-lasting Impact of Childhood Gun Injuries on Survivors and Families and the Importance of Gun Safety Promotion
Firearms have been the leading cause of death among children and teens in the U.S. since [...]
Vertex Pharmaceuticals Misses Q3 Sales Estimates Due to Weak Demand for Older CF Treatments
Vertex Pharmaceuticals missed Wall Street estimates for Q3 sales, primarily due to weaker demand for older [...]
